Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$126,316,026
+$121,300,432 QoQ
Shares Held
9,349,817
+2220.9% QoQ
Ownership
0.803%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Mar 31, 2026CallValue
$40,530
CallShares
3,000
PutValue
$10,808
PutShares
800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
9,349,817 | $126,316,026 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
508,977 | $67,052,628 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
611,747 | $46,401,008 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
75,977 | $45,052,841 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
2,664,306 | $36,900,638 | |
| 6 | ALKS |
Alkermes plc.
|
999,322 | $35,336,024 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,382,412 | $33,081,118 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
748,812 | $24,763,212 |
All Filings in VTRS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $126,316,026 | 9,349,817 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $10,808 | 800 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $40,530 | 3,000 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $5,015,594 | 402,859 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $3,135,062 | 316,673 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $5,183,480 | 580,457 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,259,844 | 259,454 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $14,587,813 | 1,171,712 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $599,273 | 51,617 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $11,704,703 | 1,101,101 | Shares | Other | 2024-08-14 | |
| 2023-03-31 | $3,494,801 | 363,285 | Shares | Other | 2023-05-15 | |
| 2022-09-30 | $7,215,016 | 846,833 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $4,113,767 | 392,910 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $88,021,113 | 8,090,176 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $32,852,192 | 2,428,100 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $8,103,685 | 598,058 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $201,895 | 14,900 | Put | Sole | 2021-11-15 | |
| 2020-12-31 | $877,275 | 46,813 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||